Hers vs Shed: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Shed beats Hers overall, scoring 7.8/10 vs 7.3/10. Shed is more affordable at $199/mo vs $348/mo. Choose Hers for women who want glp-1 access from a well-known, publicly trad. Choose Shed for users who want fast delivery and a streamlined compounded gl.
A side-by-side comparison of Hers and Shed covering pricing, scores, medication types, insurance, and more to help you decide.
Hers
#33 of 40The women's health arm of Hims & Hers Health (NYSE: HIMS), offering compounded GLP-1 medications with a polished app experience designed for women's health needs.
Visit HersShed
#16 of 40Newer GLP-1 provider focused on speed and simplicity — fast approvals, fast shipping, and a clean user experience at a competitive price point.
Visit Shed| Feature | Hers | Shed |
|---|---|---|
| Our Score | 7.3/10 | 7.8/10 |
| Starting Price | $348/mo | $199/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Women who want GLP-1 access from a well-known, publicly traded telehealth brand | Users who want fast delivery and a streamlined compounded GLP-1 experience |
| Ranking | #33 | #16 |
Pros & Cons Compared
Hers
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Women-focused branding, content, and support — not a men's health platform with a women's tab
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Broader women's health platform — can address hormonal, skin, and wellness needs alongside weight loss
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Shed
Pros
- +Industry-leading delivery speed — most patients receive medication within 2-3 days of enrollment
- +$149/mo is competitively priced for an all-inclusive compounded program with good support
- +Streamlined onboarding with no video call — approved and shipped faster than most competitors
- +Clean, modern UX with real-time shipping tracking and easy provider messaging
Cons
- −Compounded semaglutide and tirzepatide only — no brand-name options
- −Newer company (founded 2024) with limited track record and outcome data
- −No insurance billing and no FSA/HSA superbills currently available
- −Clinical support is responsive but less proactive than premium platforms
Our Verdict
Shed edges out Hers with a score of 7.8/10 vs 7.3/10. If budget is your priority, Shed starts at $199/mo compared to Hers's $348/mo. Choose Hers if you want: women who want glp-1 access from a well-known, publicly traded telehealth brand. Choose Shed if you want: users who want fast delivery and a streamlined compounded glp-1 experience.